Experts call for rapid tests to combat mpox and H5N1 bird flu outbreaks

The World Health Organization has declared mpox a public health emergency, with over 46,000 suspected cases and 1,000 deaths reported this year. Testing remains inadequate, with only 37% of suspected cases in the Democratic Republic of Congo confirmed through lab tests. The U.S. is also monitoring H5N1 bird flu, which has affected dairy cows and resulted in 46 human cases. Currently, there are no FDA-approved rapid tests specifically for H5N1, and only one rapid test for mpox was approved recently. Experts suggest developing "triple rapid tests" that can quickly adapt to new pathogens, be deployed widely, and provide fast results. They emphasize the need for increased funding, streamlined regulatory processes, and sustainable demand to enhance testing capabilities for future outbreaks.